SOLUMER®
based on interaction of insoluble-lipophilic molecule with polymers resulting in a solid composition. When in aqueous media the lipophilic compound dissolves faster and to a higher extent, enhancing the drug bioavailability
OMEXA®
Sublingual composition that provides better permeability of insoluble drugs through oral mucosa and faster onset of action
NASAX®
Powdered composition for intranasal delivery comprised of uniform spherical API and a carrier approved for inhalations. The active compound’s shape, size and morphology in combination with a device provides a precise delivery of the drug to the upper nose and brain via olfactory bulb thus bypassing the BBB.